Learn about the key changes to Medicare prescription drug coverage in 2026, including a new out-of-pocket cap, insulin cost ...

A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

Philadelphia-based Jefferson Health and Thomas Jefferson University filed a federal lawsuit Dec. 30 alleging that three insulin manufacturers and the nation’s largest pharmacy benefit managers ...

Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...

Indiana Attorney General Todd Rokita is accusing Eli Lilly of conspiring with its competitors to artifically raise the price ...

CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is ...

California is the first state in the country to partner with a nonprofit to develop, produce and sell its own insulin.

California will cap insulin co-pays at $35 and launch CalRx state-branded insulin in 2026 under new legislation signed by ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...

The lawsuit alleges insulin can cost Eli Lilly just a few dollars to produce, while some consumers are charged hundreds of ...

The Philadelphia region’s largest health system has sued several drugmakers and pharmacy benefit managers, alleging ...